Sanofi-GSK COVID-19 Vaccine Shows Positive Results in New Trial

Sanofi-GSK COVID-19 Vaccine Shows Positive Results in New Trial
The logo of French drug maker Sanofi is seen in Paris on Nov. 30, 2020. Thibault Camus/AP Photo
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:

A COVID-19 vaccine produced in a partnership between Sanofi and GlaxoSmithKline showed strong results in a new trial, the companies announced on May 17.

Interim results from a phase two trial showed the development of antibodies against the CCP (Chinese Communist Party) virus in 95 to 100 percent of volunteers, who ranged in age from 18 to 95.
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics